The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
Assessing readmission after axicabtagene ciloleucel immunotherapy.
 
Paula Perkins
No Relationships to Disclose
 
Aisling Cearley
No Relationships to Disclose
 
Angela Kirk
No Relationships to Disclose
 
Mazyar Shadman
Consulting or Advisory Role - Abbvie; ADC Therapeutics; AstraZeneca; Atara Biotherapeutics; Cellectar; Genentech; Sound Biologics; Verastem
Research Funding - Abbvie (Inst); Acerta Pharma (Inst); BeiGene (Inst); Celgene (Inst); Emergent BioSolutions (Inst); Genentech (Inst); Gilead Sciences (Inst); Merck (Inst); MustangBio (Inst); Pharmacyclics (Inst); Sunesis Pharmaceuticals (Inst); TG Therapeutics (Inst)
 
David G. Maloney
Consulting or Advisory Role - Celgene; Eureka Therapeutics; Genentech/Roche; Gilead Sciences; Kite, a Gilead company; Novartis
Research Funding - Celgene (Inst); Juno Therapeutics (Inst); Kite, a Gilead company (Inst)
Patents, Royalties, Other Intellectual Property - Inventor on 4 provisional patents.